|
ITGAV expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.3735999811243E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.03629993475352E-10 |
| Normal-vs-Stage2 |
4.083000E-03 |
| Normal-vs-Stage3 |
2.037900E-02 |
| Normal-vs-Stage4 |
4.145700E-02 |
| Stage1-vs-Stage2 |
7.767700E-02 |
| Stage1-vs-Stage3 |
3.222100E-02 |
| Stage1-vs-Stage4 |
1.516830E-01 |
| Stage2-vs-Stage3 |
6.191400E-01 |
| Stage2-vs-Stage4 |
9.179600E-01 |
| Stage3-vs-Stage4 |
7.876200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.72739999976446E-08 |
| Normal-vs-AfricanAmerican |
1.1946000000318E-06 |
| Normal-vs-Asian |
8.223300E-03 |
| Caucasian-vs-AfricanAmerican |
8.319400E-01 |
| Caucasian-vs-Asian |
6.819600E-01 |
| AfricanAmerican-vs-Asian |
7.354600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.82510000024917E-08 |
| Normal-vs-Female |
3.642300E-02 |
| Male-vs-Female |
3.83190000000644E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.66110000000242E-05 |
| Normal-vs-Extreme_Weight |
1.64540048253059E-10 |
| Normal-vs-Obese |
1.363200E-04 |
| Normal-vs-Extreme_Obese |
1.20329999997448E-06 |
| Normal_Weight-vs-Extreme_Weight |
1.671810E-01 |
| Normal_Weight-vs-Obese |
6.854200E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.974770E-01 |
| Extreme_Weight-vs-Obese |
3.839600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.905800E-01 |
| Obese-vs-Extreme_Obese |
7.092500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.706100E-02 |
| Normal-vs-Age(41-60Yrs) |
4.66539999999238E-06 |
| Normal-vs-Age(61-80Yrs) |
4.11030098845799E-11 |
| Normal-vs-Age(81-100Yrs) |
2.67490000005477E-06 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.860400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.096000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.530400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.543700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.177600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.106200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.88350000543502E-08 |
| Normal-VS-Type2 PRCC |
6.567300E-04 |
| Normal-VS-KIRP CIMP |
6.751600E-01 |
| Normal-VS-Unclassified PRCC |
2.839900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
6.361800E-04 |
| Type1 PRCC-VS-KIRP CIMP |
2.292200E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.579900E-04 |
| Type2 PRCC-VS-KIRP CIMP |
1.007250E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.851600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
8.477800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.70352999999679E-05 |
| Normal-vs-N1 |
1.513600E-02 |
| Normal-vs-N2 |
5.960200E-01 |
| N0-vs-N1 |
1.673630E-01 |
| N0-vs-N2 |
1.704110E-02 |
| N1-vs-N2 |
1.190550E-01 |
|
|
